Published in Br J Pharmacol on September 01, 1998
Computational and experimental approaches to reveal the effects of single nucleotide polymorphisms with respect to disease diagnostics. Int J Mol Sci (2014) 0.86
Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br J Pharmacol (2000) 0.81
Respiratory actions of tachykinins in the nucleus of the solitary tract: effect of neonatal capsaicin pretreatment. Br J Pharmacol (2000) 0.80
Rimonabant, gastrointestinal motility and obesity. Curr Neuropharmacol (2012) 0.75
Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys (2000) 1.57
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J Med Microbiol (1988) 1.54
Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci (1995) 1.51
Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J Gen Microbiol (1990) 1.40
Further evidence for involvement of adenosine-5'-triphosphate in non-adrenergic non-cholinergic relaxation of the isolated rat duodenum. Eur J Pharmacol (1985) 1.33
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther (1991) 1.24
An electrophysiological analysis of the effect of reactive blue 2, a putative P2-purinoceptor antagonist, on inhibitory junction potentials of rat caecum. Eur J Pharmacol (1986) 1.18
Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations. J Cardiovasc Pharmacol (1982) 1.13
Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br J Pharmacol (1988) 1.11
Pharmacological evidence that at least two different non-adrenergic non-cholinergic inhibitory systems are present in the rat small intestine. Eur J Pharmacol (1986) 1.11
Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin Exp Immunol (1991) 1.10
Effect of capsaicin on PAF-induced bronchial hyperresponsiveness and pulmonary cell accumulation in the rabbit. Br J Pharmacol (1991) 1.04
Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells. Cell Immunol (1989) 1.02
Extrinsic origin of the capsaicin-sensitive innervation of rat duodenum: possible involvement of calcitonin gene-related peptide (CGRP) in the capsaicin-induced activation of intramural non-adrenergic non-cholinergic neurons. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.01
Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite. Chem Res Toxicol (2000) 0.99
Evidence that GABAA receptors mediate relaxation of rat duodenum by activating intramural nonadrenergic-noncholinergic neurones. J Auton Pharmacol (1984) 0.99
Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Methods (1991) 0.98
Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.97
Capsaicin desensitization protects from antigen-induced bronchospasm in conscious guinea-pigs. Eur J Pharmacol (1987) 0.97
Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart. J Pharmacol Exp Ther (1991) 0.96
The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of capsaicin-sensitive afferents in the guinea-pig isolated bronchus. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.96
Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation. J Clin Invest (1994) 0.96
Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology (1993) 0.96
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. Eur J Pharmacol (2001) 0.95
Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril. J Int Med Res (2005) 0.94
Octylonium bromide: a smooth muscle relaxant which interferes with calcium ions mobilization. Arch Int Pharmacodyn Ther (1983) 0.94
Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat. J Pharmacol Exp Ther (1993) 0.92
Characterization of a peripheral vanilloid (capsaicin) receptor in the urinary bladder of the rat. Life Sci (1993) 0.92
5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies. Mol Pharmacol (1995) 0.92
Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors. Br J Cancer (1999) 0.91
Infravesical outflow obstruction in rats: a comparison of two models. Gen Pharmacol (1989) 0.91
Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo. J Natl Cancer Inst (1997) 0.90
Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microbiol (1993) 0.90
New developments in antitumor anthracyclines. Pharmacol Ther (1998) 0.89
Inhibitory effect of GABA on sympathetic neurotransmission in rabbit ear artery. Arch Int Pharmacodyn Ther (1985) 0.89
The effect of nifedipine on spontaneous, drug-induced and reflexly-activated contractions of the rat urinary bladder: evidence for the participation of an intracellular calcium store to micturition contraction. Gen Pharmacol (1988) 0.89
Cutaneous lesions in capsaicin-pretreated rats. A trophic role of capsaicin-sensitive afferents? Naunyn Schmiedebergs Arch Pharmacol (1987) 0.88
Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells. J Neuroimmunol (1998) 0.88
Induction by histamine of oscillatory activity in sheep Purkinje fibers and suppression by verapamil or lidocaine. J Cardiovasc Pharmacol (1980) 0.86
Nonadrenergic, noncholinergic inhibitory control of the rat external urethral sphincter: involvement of nitric oxide. J Pharmacol Exp Ther (1993) 0.86
Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients. Eur J Cancer (1991) 0.86
Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activation. J Neuroimmunol (1995) 0.85
Isbufylline, a xanthine derivative, inhibits bronchoconstrictor responses produced by stimulation of capsaicin-sensitive sensory nerves in guinea-pig: 'In vitro' and 'in vivo' evidence. Pulm Pharmacol (1993) 0.85
Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J Pharmacol Exp Ther (2001) 0.85
Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat. J Cardiovasc Pharmacol (2000) 0.85
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts. Clin Cancer Res (1998) 0.84
Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft. Br J Cancer (2000) 0.84
Topoisomerase poisoning activity of novel disaccharide anthracyclines. Mol Pharmacol (1999) 0.84
Capsaicin activates neurogenic non-adrenergic non-cholinergic relaxations of the isolated rat duodenum. Eur J Pharmacol (1986) 0.83
Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue. Br J Pharmacol (2001) 0.83
GABAA receptor-mediated positive inotropism in guinea-pig isolated left atria: evidence for the involvement of capsaicin-sensitive nerves. Br J Pharmacol (1989) 0.83
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft. Cancer Chemother Pharmacol (2007) 0.83
Pro- and anti-inflammatory actions of ricinoleic acid: similarities and differences with capsaicin. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.82
MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors. J Pharmacol Exp Ther (1994) 0.82
The effect of neonatal capsaicin on the development of bronchial hyperresponsiveness in allergic rabbits. Eur J Pharmacol (1993) 0.82
Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists. Eur J Pharmacol (1999) 0.82
Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line. Neurosci Lett (1994) 0.81
Contribution of neurogenic and myogenic factors in the response of rat proximal colon to distension. Am J Physiol (1987) 0.81
Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system. Proc Natl Acad Sci U S A (1991) 0.81
Milwaukee shoulder with massive bilateral cysts: effective therapy for hydrops of the shoulder. J Rheumatol (1997) 0.80
Contribution of neurogenic and myogenic factors to the contractile activity of the guinea-pig distal colon in vivo and in vitro. J Auton Pharmacol (1985) 0.80
Effect of ricinoleic acid in acute and subchronic experimental models of inflammation. Mediators Inflamm (2000) 0.80
Topical capsaicin administration protects against trinitrobenzene sulfonic acid-induced colitis in the rat. Eur J Pharmacol (1993) 0.80
Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist. Eur J Pharmacol (1998) 0.80
Regional differences of adenylate cyclase stimulation by calcitonin and calcitonin gene-related peptide in the human kidney. J Clin Endocrinol Metab (1989) 0.80
Regulation of voltage-dependent excitatory responses to alpha,beta-methylene ATP, ATP and non-adrenergic nerve stimulation by dihydropyridines in the guinea-pig vas deferens. Neuroscience (1988) 0.80
Electrocorticographic desynchronization after application of visceral and somatic noxious stimuli in urethane-anesthetized rats: effect of intrathecal administration of tachykinin (NK 1 or NK 2) receptor antagonists. J Pharmacol Exp Ther (1996) 0.80
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist. Eur J Pharmacol (1990) 0.80
Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice. Eur J Cancer (2001) 0.80
Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways. Neuropeptides (1997) 0.79
Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways. Am J Respir Crit Care Med (1995) 0.79
Effects of selective tachykinin receptor antagonists on capsaicin- and tachykinin-induced bronchospasm in anaesthetized guinea-pigs. Eur J Pharmacol (1992) 0.79
Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs. Am Rev Respir Dis (1993) 0.79
Pharmacologic and neurochemical evidence for the activation of capsaicin-sensitive sensory nerves by lipoxin A4 in guinea pig bronchus. Am Rev Respir Dis (1992) 0.79
The influence of some cardiodepressant drugs on the histamine-induced restoration of contractility in potassium-depolarized heart preparations. Arch Int Pharmacodyn Ther (1981) 0.79
In vitro degradation of a polymeric dye (Poly R-478) by manganese peroxidase. Biotechnol Bioeng (2001) 0.79
Functional effects of a monoclonal antibody directed against a distinct epitope on 4F2 molecular complex in human peripheral blood mononuclear cell activation. Cell Immunol (1991) 0.79
Continuous production of manganese peroxidase by Phanerochaete chrysosporium immobilized on polyurethane foam in a pulsed packed-bed bioreactor. Biotechnol Bioeng (1997) 0.79
Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs. J Vet Med A Physiol Pathol Clin Med (2006) 0.78
IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed. Arch Int Pharmacodyn Ther (1991) 0.78
Aminophylline-induced contractions of rabbit ear artery in high-K+ Ca2+-free medium. J Pharm Pharmacol (1982) 0.78
A mutation changes ligand selectivity and transmembrane signaling preference of the neurokinin-1 receptor. J Biol Chem (1997) 0.78
Constitutive expression of E- and P-selectin cognate ligands in human endothelial cells. Mediators Inflamm (1998) 0.78
Protective effect of the tachykinin NK2 receptor antagonist nepadutant in acute rectocolitis induced by diluted acetic acid in guinea-pigs. Neuropeptides (2000) 0.78
Capsaicin-induced relaxation in the rat isolated external urethral sphincter: characterization of the vanilloid receptor and mediation by CGRP. Br J Pharmacol (1993) 0.78
Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.77
Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors. J Pharmacol Exp Ther (1986) 0.77
Improved discriminatory properties between human and murine tachykinin NK1 receptors of MEN 10930: a new potent and competitive antagonist. Neuropeptides (1997) 0.77
Effect of the long-acting tachykinin NK(1) receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets. Br J Pharmacol (2001) 0.77
Alpha-adrenoceptor subtypes and Ca2+ mobilization in the rabbit ear artery. J Pharm Pharmacol (1983) 0.77
Opposite modulation by tachykinin (NK1) and CGRP receptors of sympathetic control of mouse vas deferens motility. Eur J Pharmacol (1995) 0.77
Resolution and pharmacological properties of the enantiomers of the potent alpha-adrenoceptor antagonist 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine. Arzneimittelforschung (1988) 0.77
Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding. Eur J Pharmacol (1994) 0.77
Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties. Eur J Pharmacol (2000) 0.77
A new method for assessing Ca2+ requirements for vasoconstriction in the rat isolated perfused kidney. Effect of norepinephrine and endothelin. J Pharmacol Toxicol Methods (1993) 0.77
A simple procedure for assessing norepinephrine-induced cellular and extracellular Ca++ mobilization in rabbit ear artery. J Pharmacol Methods (1982) 0.77
The rat external urethral sphincter an in vitro model to evaluate the activity of drugs on the smooth and striated components of the urinary bladder outlet. J Pharmacol Toxicol Methods (1992) 0.77
Contribution of cellular and extracellular Ca2+ during 5-hydroxytryptamine-induced contractions of rabbit ear artery. Eur J Pharmacol (1983) 0.77
Effect of active sensitization on the bronchopulmonary responses to tachykinins in the guinea pig. Modulation by peptidase inhibitors. J Pharmacol Exp Ther (1993) 0.77